A. Senturk Et Al. , "Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.," Molecular cancer research : MCR , vol.19, pp.1322-1337, 2021
Senturk, A. Et Al. 2021. Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.. Molecular cancer research : MCR , vol.19 , 1322-1337.
Senturk, A., Sahin, A. T., Armutlu, A., Kiremit, M. C., Acar, O., Erdem, S., ... Bagbudar, S.(2021). Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.. Molecular cancer research : MCR , vol.19, 1322-1337.
Senturk, Aydanur Et Al. "Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.," Molecular cancer research : MCR , vol.19, 1322-1337, 2021
Senturk, Aydanur Et Al. "Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.." Molecular cancer research : MCR , vol.19, pp.1322-1337, 2021
Senturk, A. Et Al. (2021) . "Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.." Molecular cancer research : MCR , vol.19, pp.1322-1337.
@article{article, author={Aydanur Senturk Et Al. }, title={Quantitative proteomics identifies secreted diagnostic biomarkers as well as tumor-dependent prognostic targets for clear cell Renal Cell Carcinoma.}, journal={Molecular cancer research : MCR}, year=2021, pages={1322-1337} }